- Home
- CERS vs FINW Comparison
CERS vs FINW Comparison
Compare CERS & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- FINW
- Stock Information
- Founded
- CERS 1991
- FINW 1999
- Country
- CERS United States
- FINW United States
- Employees
- CERS N/A
- FINW N/A
- Industry
- CERS EDP Services
- FINW Commercial Banks
- Sector
- CERS Technology
- FINW Finance
- Exchange
- CERS Nasdaq
- FINW Nasdaq
- Market Cap
- CERS 255.0M
- FINW 261.6M
- IPO Year
- CERS 1997
- FINW 2021
- Fundamental
- Price
- CERS $1.23
- FINW $19.27
- Analyst Decision
- CERS Strong Buy
- FINW Buy
- Analyst Count
- CERS 2
- FINW 4
- Target Price
- CERS $3.50
- FINW $20.75
- AVG Volume (30 Days)
- CERS 1.1M
- FINW 12.0K
- Earning Date
- CERS 10-29-2025
- FINW 10-23-2025
- Dividend Yield
- CERS N/A
- FINW N/A
- EPS Growth
- CERS N/A
- FINW N/A
- EPS
- CERS N/A
- FINW 0.96
- Revenue
- CERS $192,510,000.00
- FINW $74,999,000.00
- Revenue This Year
- CERS $30.03
- FINW $52.89
- Revenue Next Year
- CERS $9.37
- FINW $20.66
- P/E Ratio
- CERS N/A
- FINW $20.05
- Revenue Growth
- CERS 13.25
- FINW 10.21
- 52 Week Low
- CERS $1.12
- FINW $13.49
- 52 Week High
- CERS $2.24
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- CERS 44.31
- FINW 56.14
- Support Level
- CERS $1.17
- FINW $19.00
- Resistance Level
- CERS $1.35
- FINW $19.80
- Average True Range (ATR)
- CERS 0.07
- FINW 0.58
- MACD
- CERS -0.00
- FINW -0.09
- Stochastic Oscillator
- CERS 22.22
- FINW 59.23
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.